TRLV · Healthcare · $1.9B
$10.90-12.17%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
9/'26
6/'26 vs prev quarter
Among 60 Drug Manufacturers - Specialty & Generic peers
Quarterly Revenue Growth
“의료용 사업 매출은 2억2,200만 달러로 전 분기보다 4% 늘었고, 매출총이익률도 63%를 유지했어요.”
In the company's words · 2026 2분기 earnings call